No image published for this recall

Trilogy evo and ev300

Official notice

18 Feb 2026

HighHealth Canada

An official Health Canada notice concerns Trilogy evo and ev300. Philips Respironics prohibits the use of non-pneumatic (e.g., vibrating mesh) nebulizers (FSN 2025-CC-SRC-020) with Trilogy EVO platform ventilators (including Trilogy EVO, Trilogy EVO O2, and Trilogy EV300 ventilators). The firm notifies clients about revisions to a prior field safety notice concerning nebulized aerosol deposition on the internal flow sensor (FSN 2024-CC-SRC-013 - flow sensor nebulized aerosol deposition)Philips Respironics is no longer permitting the use of non-pneumatic nebulizers with Trilogy EVO platform ventilators.These updates are necessary for ongoing safe and compliant functioning.Philips Respironics has issued a follow-up letter to Field Safety Notice (FSN) 2026‑CC‑SRC‑002, to provide updated guidance regarding nebulizer use with the Trilogy Evo Platform ventilators (Trilogy Evo, Trilogy Evo O₂, Trilogy EV300).*Updated Guidance. Non‑pneumatic nebulizers may continue to be used, provided that they are positioned according to the updated nebulizer placement instructions, andthe warnings in the revised FSN are fully understood and followed.This update clarifies that non‑pneumatic nebulizers (e.g., vibrating mesh) may continue to be used with Trilogy Evo ventilators, if they are positioned correctly according to the updated placement instructions. This revised guidance supports continuity of care in situations where other nebulization options are limited. Philips Respironics will update the User Manual to include the new guidance on using non‑pneumatic nebulizers. A software update will also be released so the device interface clearly reflects that the guidance applies to both pneumatic and non‑pneumatic nebulizers. These updates will be included in a future release to limit repeated changes for users.NOTE: This update does not change the previously communicated information regarding:• Nebulized aerosol deposition on the internal flow sensor (FSN 2024-CC-SRC-013 – Flow Sensor Nebulized Aerosol Deposition)For further support, contact your local Philips representative. Published 2026-02-18.

What to do now

Contact the manufacturer if you require additional information.

Recall number

81599

Official notice

2026-02-18

The hazard

Philips Respironics prohibits the use of non-pneumatic (e.g., vibrating mesh) nebulizers (FSN 2025-CC-SRC-020) with Trilogy EVO platform ventilators (including Trilogy EVO, Trilogy EVO O2, and Trilogy EV300 ventilators). The firm notifies clients about revisions to a prior field safety notice concerning nebulized aerosol deposition on the internal flow sensor (FSN 2024-CC-SRC-013 - flow sensor nebulized aerosol deposition)Philips Respironics is no longer permitting the use of non-pneumatic nebulizers with Trilogy EVO platform ventilators.These updates are necessary for ongoing safe and compliant functioning.Philips Respironics has issued a follow-up letter to Field Safety Notice (FSN) 2026‑CC‑SRC‑002, to provide updated guidance regarding nebulizer use with the Trilogy Evo Platform ventilators (Trilogy Evo, Trilogy Evo O₂, Trilogy EV300).*Updated Guidance. Non‑pneumatic nebulizers may continue to be used, provided that they are positioned according to the updated nebulizer placement instructions, andthe warnings in the revised FSN are fully understood and followed.This update clarifies that non‑pneumatic nebulizers (e.g., vibrating mesh) may continue to be used with Trilogy Evo ventilators, if they are positioned correctly according to the updated placement instructions. This revised guidance supports continuity of care in situations where other nebulization options are limited. Philips Respironics will update the User Manual to include the new guidance on using non‑pneumatic nebulizers. A software update will also be released so the device interface clearly reflects that the guidance applies to both pneumatic and non‑pneumatic nebulizers. These updates will be included in a future release to limit repeated changes for users.NOTE: This update does not change the previously communicated information regarding:• Nebulized aerosol deposition on the internal flow sensor (FSN 2024-CC-SRC-013 – Flow Sensor Nebulized Aerosol Deposition)For further support, contact your local Philips representative.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Skus

CA2110X12B, CA2200X12B

Other

RA RA-81599

Model Numbers

CA2110X12B, CA2200X12B

Recall Numbers

81599

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

Lot or serial number - Not applicable., Model or catalogue number - CA2110X12B

Product 2

Lot or serial number - Not applicable., Model or catalogue number - CA2200X12B

Risk / hazard

Philips Respironics prohibits the use of non-pneumatic (e.g., vibrating mesh) nebulizers (FSN 2025-CC-SRC-020) with Trilogy EVO platform ventilators (including Trilogy EVO, Trilogy EVO O2, and Trilogy EV300 ventilators). The firm notifies clients about revisions to a prior field safety notice concerning nebulized aerosol deposition on the internal flow sensor (FSN 2024-CC-SRC-013 - flow sensor nebulized aerosol deposition)Philips Respironics is no longer permitting the use of non-pneumatic nebulizers with Trilogy EVO platform ventilators.These updates are necessary for ongoing safe and compliant functioning.Philips Respironics has issued a follow-up letter to Field Safety Notice (FSN) 2026‑CC‑SRC‑002, to provide updated guidance regarding nebulizer use with the Trilogy Evo Platform ventilators (Trilogy Evo, Trilogy Evo O₂, Trilogy EV300).*Updated Guidance. Non‑pneumatic nebulizers may continue to be used, provided that they are positioned according to the updated nebulizer placement instructions, andthe warnings in the revised FSN are fully understood and followed.This update clarifies that non‑pneumatic nebulizers (e.g., vibrating mesh) may continue to be used with Trilogy Evo ventilators, if they are positioned correctly according to the updated placement instructions. This revised guidance supports continuity of care in situations where other nebulization options are limited. Philips Respironics will update the User Manual to include the new guidance on using non‑pneumatic nebulizers. A software update will also be released so the device interface clearly reflects that the guidance applies to both pneumatic and non‑pneumatic nebulizers. These updates will be included in a future release to limit repeated changes for users.NOTE: This update does not change the previously communicated information regarding:• Nebulized aerosol deposition on the internal flow sensor (FSN 2024-CC-SRC-013 – Flow Sensor Nebulized Aerosol Deposition)For further support, contact your local Philips representative.

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

CA · Canada

Affected area 1

CA · Canada

Company & contacts

Brand

Manufacturer

Not provided

Phone

Not provided

Brand: Philips.

Source & status

Source

Health Canada

Tier

beta

Category

HEALTH

Classification

Type I

App estimate

high

Recall details

Recall number

81599

Classification

Type I

Source tier

beta

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Related recalls

HEALTH
Medium

Azurion and allura xper systems

Health Canada6 May 2026

Brand match

Medium risk

Markets

CA
HEALTH
Medium

Philips allura xper systems

Health Canada4 Jun 2026

Brand match

Medium risk

Markets

CA
HEALTH
Critical

Hard disk drives in azurion and allura systems

Health Canada15 May 2026

Brand match

Critical risk

Markets

CA
HEALTH
Critical

Azurion systems

Health Canada7 May 2026

Brand match

Critical risk

Markets

CA
HEALTH
Critical

Ingenia and achieva systems

Health Canada16 Apr 2026

Brand match

Critical risk

Markets

CA
HEALTH
Medium

Aneurysmflow

Health Canada2 Apr 2026

Brand match

Medium risk

Markets

CA
HEALTH
Medium

Allura xper and azurion systems

Health Canada17 Mar 2026

Brand match

Medium risk

Markets

CA
HEALTH
Critical

Philips intellivue patient monitors

Health Canada20 Feb 2026

Brand match

Critical risk

Markets

CA
HEALTH
Critical

Allura xper and allura cv20 systems

Health Canada6 Jan 2026

Brand match

Critical risk

Markets

CA
HEALTH
Medium

Patient information center ix

Health Canada31 Dec 2025

Brand match

Medium risk

Markets

CA
HEALTH
Critical

Azurion r2.1.10 and r2.2.10 systems

Health Canada29 Dec 2025

Brand match

Critical risk

Markets

CA
HEALTH
Medium

Philips diagnostic x-ray systems

Health Canada16 Oct 2025

Brand match

Medium risk

Markets

CA

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 18 Feb 2026. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.